![](/img/cover-not-exists.png)
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin
A. MANGIA, O. DALGARD, N. MINERVA, H. VERBAAN, D. BACCA, H. RING-LARSEN, M. COPETTI, V. CARRETTA, V. PIAZZOLLA, R. COZZOLONGO, L. MOTTOLA, A. ANDRIULLIVolume:
31
Year:
2010
Language:
english
Pages:
8
DOI:
10.1111/j.1365-2036.2010.04290.x
File:
PDF, 132 KB
english, 2010